Singular Genomics Systems Investor Relations Material
Latest events
Q2 2024
Singular Genomics Systems
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Singular Genomics Systems Inc
Access all reports
Singular Genomics Systems Inc. is a life sciences technology company focused on developing next-generation sequencing (NGS) platforms and genomic analysis solutions. The company’s flagship products include the G4 Sequencing Platform, designed to deliver fast, accurate, and flexible sequencing for research and clinical applications. Singular Genomics aims to support areas such as oncology, immunology, and inherited disease research. Singular Genomics is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
OMIC
Country
🇺🇸 United States